Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOX-100 for Preventing Hypotension During Hemodialysis
NCT01672008Phase 2Completed
- Sponsor
- Medinox, Inc.
- Start
- Aug 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NOX-100 in intradialytic hypotension (IDH), sponsored by Medinox, Inc.. Started Aug 2012; status: completed.
02
Drugs
NOX-100
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on NCT01672008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01672008.